Showing results (841-850 of 1,126) with videos related to

Sort By:
Pageof 113
Frontiers in Plant Science|August 1, 2020
A Conditional Mutation in SCD1 Reveals Linkage Between PIN Protein Trafficking, Auxin Transport, Gravitropism, and Lateral Root InitiationCarole L Gibson, Jonathan W Isley, Tanya G Falbel, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|March 13, 2026
Guidelines to the Practice of Anesthesia-Revised Edition 2026Gregory R Dobson, Alex Beomju Bak, Anthony Chau, et al.
Diabetes Care|February 14, 2018
Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell FailureRebecca L Hull, Ronald L Gibson, Sharon McNamara, et al.
Current Medical Research and Opinion|January 1, 1989
A single-blind, placebo-controlled study of glycosaminoglycan-peptide complex ('Rumalon') in patients with osteoarthritis of the hip or kneeR J Gramajo, E J Cutroneo, D E Fernandez, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|February 8, 2012
Evidence-based recommendations for the development of obesity prevention programs targeted at preschool childrenC D Summerbell, H J Moore, C Vögele, et al.
Plos Neglected Tropical Diseases|April 1, 2025
Potential vertical transmission of genetically diverse Trypanosoma cruzi in natural rodent populationsNathaniel L Gibson, Bruno M Ghersi, Bridget Knudson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 8, 2021
Association Between Number of Intravenous Antipseudomonal Antibiotics and Clinical Outcomes of Pediatric Cystic Fibrosis Pulmonary ExacerbationsJonathan D Cogen, Anna V Faino, Frankline Onchiri, et al.
Investigational New Drugs|March 20, 2019
A phase I, dose-escalation study of PF-06650808, an anti-Notch3 antibody-drug conjugate, in patients with breast cancer and other advanced solid tumorsLee S Rosen, Robert Wesolowski, Raffaele Baffa, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 29, 2011
Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosaC E Wainwright, A L Quittner, D E Geller, et al.
Pediatric Pulmonology|July 31, 2010
An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosisChristopher M Oermann, George Z Retsch-Bogart, Alexandra L Quittner, et al.
Pageof 113